DraftKings Inc.
DKNG · NASDAQ
Analyst ratings
strong_buy · 29 ratings
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| July 15, 2026 | JP Morgan | Maintains | Overweight | $34.00 |
| July 10, 2026 | TD Cowen | Maintains | Buy | $35.00 |
| July 9, 2026 | Deutsche Bank | Maintains | Hold | $28.00 |
| July 1, 2026 | Susquehanna | Maintains | Positive | $31.00 |
| June 25, 2026 | Citizens | Maintains | Market Outperform | $36.00 |
| June 24, 2026 | Guggenheim | Reiterates | Buy | $35.00 |
| June 22, 2026 | Citizens | Reiterates | Market Outperform | $34.00 |
| June 8, 2026 | TD Cowen | Reiterates | Buy | $30.00 |
| June 5, 2026 | UBS | Maintains | Buy | $49.00 |
| May 14, 2026 | Morgan Stanley | Maintains | Overweight | $39.00 |
| May 12, 2026 | Citigroup | Maintains | Buy | $30.00 |
| May 12, 2026 | Mizuho | Maintains | Outperform | $45.00 |
| May 11, 2026 | Guggenheim | Maintains | Buy | $35.00 |
| May 11, 2026 | Barclays | Maintains | Overweight | $35.00 |
| May 11, 2026 | Needham | Reiterates | Buy | $35.00 |
| May 8, 2026 | BTIG | Maintains | Buy | $30.00 |
| April 24, 2026 | MoffettNathanson | Downgrades | Neutral | $27.00 |
| April 21, 2026 | Truist Securities | Maintains | Buy | $30.00 |
| April 16, 2026 | JP Morgan | Maintains | Overweight | $31.00 |
| April 16, 2026 | Citigroup | Maintains | Buy | $29.00 |
| April 16, 2026 | Barclays | Maintains | Overweight | $33.00 |
| April 7, 2026 | Wells Fargo | Maintains | Overweight | $31.00 |
| April 1, 2026 | Citizens | Maintains | Market Outperform | $34.00 |
| March 31, 2026 | Susquehanna | Maintains | Positive | $32.00 |
| March 23, 2026 | BTIG | Reiterates | Buy | $35.00 |
| March 16, 2026 | UBS | Maintains | Buy | $43.00 |
| March 3, 2026 | Macquarie | Maintains | Outperform | $40.00 |
| March 3, 2026 | BMO Capital | Maintains | Outperform | $50.00 |
| March 3, 2026 | Citizens | Reiterates | Market Outperform | $38.00 |
| March 3, 2026 | Needham | Reiterates | Buy | $35.00 |
| March 3, 2026 | BTIG | Reiterates | Buy | $35.00 |
| February 26, 2026 | BTIG | Maintains | Buy | $35.00 |
| February 24, 2026 | Morgan Stanley | Maintains | Overweight | $40.00 |
| February 17, 2026 | JP Morgan | Maintains | Overweight | $32.00 |
| February 17, 2026 | Goldman Sachs | Maintains | Buy | $31.00 |
| February 17, 2026 | Stifel | Maintains | Buy | $40.00 |
| February 17, 2026 | Citigroup | Maintains | Buy | $32.00 |
| February 17, 2026 | Truist Securities | Maintains | Buy | $33.00 |
| February 17, 2026 | Barclays | Maintains | Overweight | $37.00 |
| February 17, 2026 | Mizuho | Maintains | Outperform | $44.00 |
| February 17, 2026 | Macquarie | Maintains | Outperform | $40.00 |
| February 17, 2026 | Oppenheimer | Maintains | Outperform | $35.00 |
| February 17, 2026 | Needham | Maintains | Buy | $35.00 |
| February 13, 2026 | Canaccord Genuity | Maintains | Buy | $44.00 |
| February 13, 2026 | BTIG | Maintains | Buy | $37.00 |
| February 13, 2026 | Benchmark | Maintains | Buy | $29.00 |
| February 13, 2026 | B of A Securities | Maintains | Neutral | $30.00 |
| February 3, 2026 | Canaccord Genuity | Maintains | Buy | $50.00 |
| January 30, 2026 | Stifel | Maintains | Buy | $44.00 |
| January 29, 2026 | Guggenheim | Maintains | Buy | $42.00 |
| January 16, 2026 | Morgan Stanley | Maintains | Overweight | $53.00 |
| January 15, 2026 | Wells Fargo | Upgrades | Overweight | $49.00 |
| December 22, 2025 | Truist Securities | Maintains | Buy | $43.00 |
| December 5, 2025 | BTIG | Maintains | Buy | $45.00 |
| November 19, 2025 | Needham | Reiterates | Buy | $52.00 |
| November 13, 2025 | Mizuho | Maintains | Outperform | $46.00 |
| November 10, 2025 | Citigroup | Maintains | Buy | $48.00 |
| November 10, 2025 | Barclays | Maintains | Overweight | $40.00 |
| November 10, 2025 | Macquarie | Maintains | Outperform | $48.00 |
| November 10, 2025 | JP Morgan | Maintains | Overweight | $42.00 |
| November 10, 2025 | Truist Securities | Maintains | Buy | $45.00 |
| November 10, 2025 | Guggenheim | Maintains | Buy | $45.00 |
| November 10, 2025 | Stifel | Reiterates | Buy | $46.00 |
| November 10, 2025 | Susquehanna | Maintains | Positive | $48.00 |
| November 10, 2025 | Bernstein | Maintains | Outperform | $41.00 |
| November 10, 2025 | Needham | Reiterates | Buy | $52.00 |
| November 7, 2025 | Canaccord Genuity | Maintains | Buy | $54.00 |
| November 7, 2025 | Benchmark | Maintains | Buy | $37.00 |
| November 7, 2025 | BTIG | Maintains | Buy | $42.00 |
| November 4, 2025 | BMO Capital | Maintains | Outperform | $63.00 |
| November 4, 2025 | B of A Securities | Downgrades | Neutral | $35.00 |
| November 3, 2025 | Bernstein | Maintains | Outperform | $50.00 |
| October 27, 2025 | Stifel | Maintains | Buy | $50.00 |
| October 21, 2025 | Truist Securities | Maintains | Buy | $50.00 |
| October 14, 2025 | Susquehanna | Maintains | Positive | $59.00 |
| October 9, 2025 | Berenberg | Upgrades | Buy | $43.00 |
| October 7, 2025 | Mizuho | Maintains | Outperform | $54.00 |
| October 6, 2025 | Jefferies | Maintains | Buy | $52.00 |
| October 2, 2025 | BTIG | Maintains | Buy | $45.00 |
| October 2, 2025 | Benchmark | Maintains | Buy | $43.00 |
| October 1, 2025 | Northland Capital Markets | Downgrades | Underperform | $33.00 |
| October 1, 2025 | Citigroup | Maintains | Buy | $56.00 |
| October 1, 2025 | Oppenheimer | Maintains | Outperform | $55.00 |
| October 1, 2025 | JMP Securities | Maintains | Market Outperform | $51.00 |
| September 24, 2025 | UBS | Maintains | Buy | $56.00 |
Profitability sustainability and path to consistent earnings
DraftKings achieved positive net income for the first time in 2025, with Q1 2026 EBITDA surging 64% year-over-year and 17% revenue growth. The company maintained its full-year 2026 revenue outlook of $6.5B–$6.9B, signaling confidence in its trajectory toward sustained profitability.
Despite the recent profitability milestone, DraftKings' elevated P/E of 280.56 demands flawless earnings consistency. Analysts caution that growth alone does not guarantee a good investment, and recent earnings misses on monthly unique payers — 4.2M versus consensus of 4.46M — raise concerns about execution.
Competitive pressures and regulatory risks in the sports betting market
DraftKings' expansion into new markets such as Alberta, alongside upcoming catalysts like the FIFA World Cup and NFL season, positions the company to capture incremental wagers. Morgan Stanley reiterated an 'overweight' rating, citing FIFA World Cup-driven upside as a near-term revenue accelerator.
Prediction market competition is intensifying, with Kalshi gaining share and recording record volumes. MoffettNathanson lowered its price target from $27 to $25, and regulatory scrutiny across jurisdictions continues to pose significant headwinds for DraftKings' ability to expand and sustain profitability.
Stock valuation relative to intrinsic value and peer comparisons
A majority of analysts maintain a 'Buy' or 'Strong Buy' consensus, with price targets ranging up to $74 and an average near $35, implying over 33% upside from current levels. DraftKings is also trading significantly below estimated future cash flow value of $87.21, suggesting meaningful undervaluation.
DraftKings' Price-to-Sales ratio of 2x exceeds the peer average of 1.4x, and its Altman Z-Score of 2.05 signals elevated financial risk. Technical indicators overwhelmingly point to selling pressure, with 72% of tracked signals on a 'Sell' reading and the stock down over 38% in the past 52 weeks.